Met Life Investment Management, LLC Icosavax, Inc. Transaction History

Met Life Investment Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.95 - $15.79 $14,047 - $37,280	2,361 Added 18.59%	15,059 $237,000
Q2 2023 Apr 29, 2024	BUY	$4.89 - $10.57 $62,093 - $134,217	12,698 New	12,698 $126,000
Q1 2023 May 09, 2024	BUY	$5.62 - $11.51 $71,362 - $146,153	12,698 New	12,698 $73.6 Million
Q4 2022 May 10, 2024	SELL	$2.32 - $10.97 $6,096 - $28,829	-2,628 Reduced 17.15%	12,698 $100,000
Q4 2022 Mar 22, 2023	SELL	$2.32 - $10.97 $6,096 - $28,829	-2,628 Reduced 17.15%	12,698 $100,000
Q4 2022 Feb 15, 2023	BUY	$2.32 - $10.97 $29,459 - $139,297	12,698 New	12,698 $100,000
Q2 2022 Aug 11, 2022	SELL	$5.7 - $10.33 $87,358 - $158,317	-15,326 Closed	0 $0
Q1 2022 May 10, 2024	BUY	$4.41 - $22.5 $67,587 - $344,835	15,326 New	15,326 $107,000
Q1 2022 Jun 20, 2023	BUY	$4.41 - $22.5 $11,589 - $59,130	2,628 Added 20.7%	15,326 $107,000
Q1 2022 Mar 22, 2023	BUY	$4.41 - $22.5 $44,404 - $226,552	10,069 Added 191.54%	15,326 $107,000
Q1 2022 May 12, 2022	BUY	$4.41 - $22.5 $44,404 - $226,552	10,069 Added 191.54%	15,326 $108,000
Q4 2021 Jun 21, 2023	SELL	$21.07 - $34.98 $156,781 - $260,286	-7,441 Reduced 58.6%	5,257 $120,000
Q3 2021 May 17, 2024	BUY	$24.85 - $40.25 $130,636 - $211,594	5,257 New	5,257 $155,000
Q3 2021 Jun 21, 2023	SELL	$24.85 - $40.25 $184,908 - $299,500	-7,441 Reduced 58.6%	5,257 $155,000
Q3 2021 Mar 22, 2023	SELL	$24.85 - $40.25 $184,908 - $299,500	-7,441 Reduced 58.6%	5,257 $155,000
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $130,636 - $211,594	5,257 New	5,257 $156,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.